166 related articles for article (PubMed ID: 24270251)
1. Clinical variables associated with leprosy reactions and persistence of physical impairment.
Oliveira DT; Sherlock J; Melo EV; Rollemberg KC; Paixão TR; Abuawad YG; Simon Mdo V; Duthie M; Jesus AR
Rev Soc Bras Med Trop; 2013; 46(5):600-4. PubMed ID: 24270251
[TBL] [Abstract][Full Text] [Related]
2. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.
van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV
Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033
[TBL] [Abstract][Full Text] [Related]
3. Clinical variables associated with disability in leprosy cases in northeast Brazil.
Santos VS; de Matos AM; de Oliveira LS; de Lemos LM; Gurgel RQ; Reis FP; Santos VT; Feitosa VL
J Infect Dev Ctries; 2015 Mar; 9(3):232-8. PubMed ID: 25771459
[TBL] [Abstract][Full Text] [Related]
4. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil.
De Oliveira CR; De Alencar Mde J; De Sena Neto SA; Lehman LF; Schreuder PA
Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579
[TBL] [Abstract][Full Text] [Related]
5. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments.
Schreuder PA
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):170-81. PubMed ID: 9728449
[TBL] [Abstract][Full Text] [Related]
6. Impairments in multibacillary leprosy; a study from Brazil.
Pimentel MI; Nery JA; Borges E; Gonçalves RR; Sarno EN
Lepr Rev; 2004 Jun; 75(2):143-52. PubMed ID: 15282965
[TBL] [Abstract][Full Text] [Related]
7. Unexplained delayed nerve impairment in leprosy after treatment.
Rosenberg NR; Faber WR; Vermeulen M
Lepr Rev; 2003 Dec; 74(4):357-65. PubMed ID: 14750581
[TBL] [Abstract][Full Text] [Related]
8. Preventing nerve function impairment in leprosy: validation and updating of a prediction rule.
Schuring RP; Richardus JH; Steyerberg EW; Pahan D; Faber WR; Oskam L
PLoS Negl Trop Dis; 2008; 2(8):e283. PubMed ID: 18846229
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for physical disability at diagnosis of 19,283 new cases of leprosy.
Moschioni C; Antunes CM; Grossi MA; Lambertucci JR
Rev Soc Bras Med Trop; 2010; 43(1):19-22. PubMed ID: 20305962
[TBL] [Abstract][Full Text] [Related]
10. Future prevalence of WHO grade 2 impairment in relation to incidence trends in leprosy: an exploration.
Meima A; van Veen NH; Richardus JH
Trop Med Int Health; 2008 Feb; 13(2):241-6. PubMed ID: 18304271
[TBL] [Abstract][Full Text] [Related]
11. Age is an important risk factor for onset and sequelae of reversal reactions in Vietnamese patients with leprosy.
Ranque B; Nguyen VT; Vu HT; Nguyen TH; Nguyen NB; Pham XK; Schurr E; Abel L; Alcaïs A
Clin Infect Dis; 2007 Jan; 44(1):33-40. PubMed ID: 17143812
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and histopathological study of leprosy cases in the state of Sergipe, Brazil.
Santos VS; Mendonça-Neto PT; Fakhouri R; Raposo OF; Reiss FP; Feitosa VL
Indian J Lepr; 2013; 85(3):93-100. PubMed ID: 24724230
[TBL] [Abstract][Full Text] [Related]
13. Leprosy and disability in children younger than 15 years in an endemic area of northeast Brazil.
Santos VS; Santos LC; Lôbo LV; Lemos LM; Gurgel RQ; Cuevas LE
Pediatr Infect Dis J; 2015 Mar; 34(3):e44-7. PubMed ID: 25389921
[TBL] [Abstract][Full Text] [Related]
14. The effect of corticosteroid usage on the bacterial killing, clearance and nerve damage in leprosy: a prospective cohort study: part 1--study design and baseline findings of 400 untreated multibacillary patients.
Khambati FA; Shetty VP; Ghate SD; Capadia GD; Pai VV; Ganapati R
Lepr Rev; 2008 Jun; 79(2):134-53. PubMed ID: 18711936
[TBL] [Abstract][Full Text] [Related]
15. Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials.
Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
Lepr Rev; 2003 Dec; 74(4):319-27. PubMed ID: 14750577
[TBL] [Abstract][Full Text] [Related]
16. Neuropathic pain in people treated for multibacillary leprosy more than ten years previously.
Saunderson P; Bizuneh E; Leekassa R
Lepr Rev; 2008 Sep; 79(3):270-6. PubMed ID: 19009976
[TBL] [Abstract][Full Text] [Related]
17. A clinical prediction rule for nerve function impairment in leprosy patients-revisited after 5 years of follow-up.
Croft RP; Nicholls PG; Steyerberg EW; Richardus JH; Withington SG; Smith WC
Lepr Rev; 2003 Mar; 74(1):35-41. PubMed ID: 12669931
[TBL] [Abstract][Full Text] [Related]
18. The relationship between detection delay and impairment in leprosy control: a comparison of patient cohorts from Bangladesh and Ethiopia.
Van Veen NH; Meima A; Richardus JH
Lepr Rev; 2006 Dec; 77(4):356-65. PubMed ID: 17343222
[TBL] [Abstract][Full Text] [Related]
19. Assessment of physical impairments in leprosy patients: a comparison between the world health organization (who) disability grade and the Eye-Hand-Foot score.
Raposo MT; Caminha AV; Heukelbach J; Sánchez-González MÁ; de Medeiros JL; Nemes MI
Rev Inst Med Trop Sao Paulo; 2011; 53(2):77-81. PubMed ID: 21537754
[TBL] [Abstract][Full Text] [Related]
20. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
Van Brakel WH; Nicholls PG; Das L; Barkataki P; Maddali P; Lockwood DN; Wilder-Smith E
Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
